Accession Number: | 0001567619-19-018505 |
Date: | 2019-09-17 |
Issuer: | BIOMARIN PHARMACEUTICAL INC (BMRN) |
Original Submission Date: |
LAWLIS V BRYAN
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA 94949
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-17 | M | 3,750 | a | $21.51 | 27,340 | direct | ||
COMMON STOCK | 2019-09-17 | S | 3,750 | d | $74.47 | 23,590 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY COMMON STOCK) | 21.51 | 2019-09-17 | deemed execution date | M | 3,750 (d) | 2010-11-12 | 2020-05-11 | common stock 3,750 | $21.51 | 7,500 | direct |
ID | footnote |
---|---|
f1 | trade made pursuant to a 10b5-1 plan executed on may 1, 2019. |
f2 | reflects the number of options outstanding after the transactions from the specific stock option grant. |